Trimodality Bladder Preservation

The aim of this study is To evaluate the outcomes of patients with muscle invasive bladder cancer managed by trimodal therapy", Neoadjuvant chemotherapy( NAC) followed by Transurethral resection of the bladder tumor then Radiotherapy, for bladder preservation and capability to reach the goal of better quality of life, compared to radical cystectomy with assessment of factors that may predict treatment response, risk of recurrences and (disease- free and over all)survival of such patients...

NCT Number	NCT07402317
Lead Sponsor	Al-Azhar University
Conditions	Bladder Cancer Treatment
Enrollment	97 participants
Start Date	2018-12-11
Primary Completion	2022-09-01 (estimated)
Study Completion	2023-01-25 (estimated)
Updated on ClinicalTrials.gov	2026-02-11